Braveheart Bio, Inc. (BRVE) Insider Trading

Over the last 3 months, BRVE insiders made 13 open-market buys and 0 sales, a net purchase of $159.0M (SEC Form 4). Multiple insiders bought within days of each other (cluster buying).

Insider Activity

Sentiment
100/100
Buys (3m)
13
Sells (3m)
0
Net (3m)
$159.0M
Insiders buyingCluster buying
DateInsiderTypeSharesPrice
Aug 11, 2026AH Bio Fund IV, L.P.10 percent ownerBuy1,100,000$18.00
Aug 11, 2026Chimovits Erezdirector, 10 percent owner: Buy1,666,667$18.00
Aug 11, 2026Chimovits Erezdirector, 10 percent owner: Buy273,333$18.00
Aug 11, 2026ORBIMED ADVISORS LLCdirector, 10 percent owner: Buy1,666,667$18.00
Aug 11, 2026ORBIMED ADVISORS LLCdirector, 10 percent owner: Buy273,333$18.00
Aug 7, 2026Chimovits Erezdirector, 10 percent owner: Grant30,000$18.00
Aug 7, 2026Viehbacher ChristopherdirectorBuy83,333$18.00
Aug 7, 2026Viehbacher ChristopherdirectorGrant30,000$18.00
Aug 7, 2026Malek David IdirectorBuy4,166$18.00
Aug 7, 2026Malek David IdirectorGrant30,000$18.00
Aug 7, 2026Anderson Michele A.officer: Chief Development OfficerBuy1,111$18.00
Aug 7, 2026Forbion Growth Opportunities Fund III Cooperatief U.A.10 percent ownerBuy1,920,000$18.00
Aug 7, 2026Murdoch Travisdirector, officer: CEO and PresidentBuy83,333$18.00
Aug 7, 2026Murdoch Travisdirector, officer: CEO and PresidentGrant550,000$19.80
Aug 7, 2026Bos JasperdirectorGrant30,000$18.00
Aug 7, 2026Lubner David CharlesdirectorBuy55,555$18.00
Aug 7, 2026Lubner David CharlesdirectorGrant60,000$18.00
Aug 7, 2026Anderson Michele A.officer: Chief Development OfficerGrant300,000$18.00
Aug 7, 2026Forbion Growth Opportunities Fund III Cooperatief U.A.10 percent ownerBuy1,680,000$18.00
Aug 7, 2026Rickey James Paulofficer: Chief Financial OfficerBuy27,777$18.00
Aug 7, 2026Rickey James Paulofficer: Chief Financial OfficerGrant300,000$18.00
Aug 7, 2026Lohoff TimdirectorGrant30,000$18.00

Source: BRVE SEC Form 4 filings, latest Aug 11, 2026. For informational purposes only — not investment advice.